Article
Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias.
Endocrine journal - 1 Jan 2010
Yasoda Akihiro, Nakao Kazuwa
Abstract excerpt
By using transgenic and knockout mice, we have elucidated that C-type natriuretic peptide (CNP) is a potent stimulator of endochondral bone growth. In humans, loss-of-function mutations in the gene coding for guanylyl cyclase-B (GC-B), the specific receptor for CNP, have been proved to be the cause of acromesomelic dysplasia, type Maroteaux, one form of human skeletal dysplasias. Following these results, we have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
